Cytosorbents (CTSO) Share-based Compensation Growth (1y) (2011 - 2026)

Cytosorbents (CTSO) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Abbott Laboratories 181.19 Bn 173.90 Bn 6.27 Bn 9.69%
2 Stryker 128.53 Bn 125.65 Bn 3.81 Bn 37.62%
3 Medtronic 107.77 Bn 98.55 Bn 6.41 Bn 6.74%
4 Boston Scientific 67.72 Bn 66.27 Bn 3.61 Bn 12.16%
5 Edwards Lifesciences 48.21 Bn 44.54 Bn 1.29 Bn 12.94%
6 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.33 Bn 26.05 Bn 1.98 Bn 59.09%
8 Smith & Nephew 26.76 Bn 26.18 Bn - -
9 Koninklijke Philips 25.27 Bn 22.15 Bn 2.07 Bn -30.44%
10 Cytosorbents 23.46 Mn 18.66 Mn 6.13 Mn -33.50%

Historic Data

Download Data
DateValue
Mar 31, 2026 -33.50%
Dec 31, 2025 -3.70%
Sep 30, 2025 135.69%
Jun 30, 2025 -42.26%
Mar 31, 2025 40,315.02%
Dec 31, 2024 -13.88%
Sep 30, 2024 -17.96%
Jun 30, 2024 73.51%
Mar 31, 2024 -99.81%
Dec 31, 2023 22.79%
Sep 30, 2023 8.06%
Jun 30, 2023 -25.10%
Mar 31, 2023 36.85%
Dec 31, 2022 137.90%
Sep 30, 2022 0.60%
Jun 30, 2022 -51.16%
Mar 31, 2022 -49.49%
Dec 31, 2021 -1,253.74%
Sep 30, 2021 -8.18%
Jun 30, 2021 48.95%